Recent SPRY News
- ARS Pharmaceuticals Submits Response for neffy® (epinephrine nasal spray) Marketing Authorization Application to EMA’s CHMP and Enters License Agreement with CSL Seqirus for Commercialization of neffy in Australia and New Zealand • GlobeNewswire Inc. • 04/30/2024 01:01:00 PM
- ARS Pharmaceuticals Submits Response to FDA Complete Response Letter for neffy® (Epinephrine Nasal Spray) • GlobeNewswire Inc. • 04/03/2024 01:01:00 PM
- ARS Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/21/2024 08:05:00 PM
- ARS Pharmaceuticals Reviews Recent Clinical Updates and Commercial Opportunity at neffy® Investor Day • GlobeNewswire Inc. • 03/07/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 05:56:52 PM
- ARS Pharmaceuticals to Participate in the Leerink Partners Global Biopharma Conference 2024 • GlobeNewswire Inc. • 03/06/2024 02:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 01:21:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 02:08:51 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 05:08:35 PM
- ARS Pharmaceuticals announces neffy® meets primary endpoints and shows rapid symptom control in Phase 2 urticaria clinical study • GlobeNewswire Inc. • 02/26/2024 02:01:00 PM
- ARS Pharmaceuticals to Host Virtual neffy® Investor Day on March 7, 2024 • GlobeNewswire Inc. • 02/22/2024 02:01:00 PM
- ARS Pharma Announces Favorable Topline Results from Repeat Dosing Study of neffy® (Epinephrine Nasal Spray) Under Nasal Allergen Challenge Conditions, Readies Data for Response to FDA’s Complete Response Letter • GlobeNewswire Inc. • 02/20/2024 02:01:00 PM
- ARS Pharmaceuticals to Present Positive Clinical Efficacy Data for neffy® (epinephrine nasal spray) at 2024 AAAAI Annual Meeting • GlobeNewswire Inc. • 02/05/2024 02:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:47:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:45:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:41:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:39:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:02:29 PM
- ARS Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/09/2023 09:00:00 PM
- ARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including Anaphylaxis • GlobeNewswire Inc. • 11/09/2023 04:02:36 PM
- ARS Pharmaceuticals to Meet With FDA on Neffy Rejection • Dow Jones News • 10/06/2023 01:57:00 PM
- ARS Pharmaceuticals Announces Scheduling of a Type A Meeting with the U.S. FDA for neffy® (epinephrine nasal spray) • GlobeNewswire Inc. • 10/06/2023 01:03:00 PM
- Single and Repeat Dose Clinical Study of neffy (epinephrine nasal spray) Published in the Journal of Allergy and Clinical Immunology • GlobeNewswire Inc. • 10/03/2023 01:03:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:17:04 PM
- ARS Pharmaceuticals Shares Sink to New Lows on FDA Neffy Setback • Dow Jones News • 09/20/2023 02:20:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM